glp-1 kidney cancer and the kidney: from physiology to pharmacology and outcomes in diabetes Frontiers | GLP-1 Receptor Agonists
Description
Diabetes Care 40 , 6976 (2017)
Interestingly, defects in mitochondrial energy metabolism are also present in the brains of patients with AD, leading to neuronal apoptosis and A deposition, which increases ROS production by interfering with mitochondrial calcium homeostasis and ETC function
Combining insights from AI, research and lived experience allows us to reach solutions faster and understand not just what works, but why
Most of these medications are not FDA approved for the use of treating dysautonomias but are used off-label. Each of these has been successfully used in treating some patients
